#HIV research

“Conditions for co-infection could exist, but to our knowledge no such cases have been identified”

“I want to be an ambassador of hope,” Adam Castillejo, 40, who grew up in Venezuela, tells The New York Times.

Over $11 million has been awarded to alternative, lab-based clinical research—and $1.2 million to Holiday Hugs.

Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.

The International AIDS Conference takes place July 6 to 10 in San Francisco and Oakland.

He recently tried an experimental brain surgery to treat his alcohol addiction.

An $80,000 grant from The Campbell Foundation will help scientist Natalia Freund continue her HIV vaccine studies.

They’re the 2019 recipients of amfAR’s Mathilde Krim Fellowship in Basic Biomedical Research.

Researcher Sannisha Dale and Project MMAGIC plan to find out.

“Young researchers such as myself…can provide a new perspective and contribute to the conversation for a cure,” says Chidera Ejikeme.

Over $12 million in grants has been awarded to the Wistar Institute to research the links between opioid receptors and immune activation.

How insidious is the reach of Big Pharma? It can affect our policy-making, and even trick people like me into shilling for them.

Meet Kimberlynn Mai. She studies the development of integrase inhibitors.

Bob Leahy says our elderly HIV-positive folks are misunderstood, under-researched and largely ignored. That has to change.

This amfAR grant hopes to find out. It’s part of $1.16 million in new funding from ARCHE.

The number of HIV docs in the South dropped 5% between 2010 and 2015, while the number of Southerners with HIV increased 14%.